Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Consider this

<< Previous

Bullboard Posts

Next >>

Comment by jfm1330on Oct 26, 2023 2:25pm

64 Views

Post# 35702665

RE:RE:RE:Consider this

Saw my oncologist yesterday for the result of my last Ga68 scan, it's stable after 7.5 months under chemo. I will stay on that as long as the disease will not progress.

SPCEO1 wrote: You are correct - my screen has not updated the market cap number yet for the new shares and I failed to think it through. Thanks for catching that.

Trusting good things are happening as a result of your treatments.
jfm1330 wrote: You cannot add the new oney and not the new shares. So market cap is around 50 M$

SPCEO1 wrote: THTX just raised $25 million or so this morning in new cash to add to the $23 million they had at the end of the last quarter. The market cap right now is $23 million.